The U.S. Food and Drug Administration has approved phase one human clinical trials in the United States of a genital warts HPV11 prophylactic vaccine developed at the University of Queensland.
16 October 1997A Member of
Privacy & Terms of use | Feedback
Authorised by: Director, Office of Marketing and Communications
ABN: 63 942 912 684
CRICOS
Provider No: 00025B